Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary. - Wikidata - awgldk - TriplyDB

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

http://www.wikidata.org/entity/Q37010393

about

Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes Effect of trajectories of glycemic control on mortality in type 2 diabetes: a semiparametric joint modeling approach.Improved health status with insulin degludec compared with insulin glargine in people with type 1 diabetes Key considerations around the risks and consequences of hypoglycaemia in people with type 2 diabetes.The impact of hypoglycaemia on quality of life and related patient-reported outcomes in Type 2 diabetes: a narrative review.Examining diabetes distress, medication adherence, diabetes self-care activities, diabetes-specific quality of life and health-related quality of life among type 2 diabetes mellitus patients.A path model of health-related quality of life in type 2 diabetic patients: a cross-sectional study in Taiwan.Health-related quality of life (EQ-5D) among type 2 diabetes mellitus patients treated with dapagliflozin over 2 years.Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria.

P2860

Q26827955-D504C801-3506-42C7-9B1F-FC20C818D697 Q33880856-6069684D-7EF8-4E92-98B9-E4BAFA13DBEA Q36097341-7F802ABF-9312-4030-A606-AC57CE910381 Q37710723-E9EBAB34-47F8-4AFC-8872-5FD646B3F3A7 Q37916689-CAE973D3-4596-4FB7-9930-046C712A3974 Q42656703-26D54BFA-D937-40C6-BC4E-6D2C93A66CE9 Q44739858-247CC1CD-08E7-4BFC-838F-0FF33D861511 Q48086602-2C84215E-703F-49E2-B20C-718D8EAD4417 Q51526347-54BE6D7B-633A-41D7-8B28-74A506DCAA92

P2860

Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.

http://www.wikidata.org/entity/Q37010393

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 31 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Outcomes of adding second hypo ...... ng type 2 diabetes in Hungary.

@en

Outcomes of adding second hypo ...... ng type 2 diabetes in Hungary.

@nl

type

label

Outcomes of adding second hypo ...... ng type 2 diabetes in Hungary.

@en

Outcomes of adding second hypo ...... ng type 2 diabetes in Hungary.

@nl

prefLabel

Outcomes of adding second hypo ...... ng type 2 diabetes in Hungary.

@en

Outcomes of adding second hypo ...... ng type 2 diabetes in Hungary.

@nl

P1433

Q37010393-0ADA97E9-6650-4570-8823-EB3616E71CE5

P1476

Q37010393-8A158CBA-1433-4183-A577-195DA929C5D4

P2093

Q37010393-0795F3A0-83B3-4643-9FB0-33674E21560D

Q37010393-2A0B03C6-05AC-41F8-A297-9F18F660362D

Q37010393-495780F3-8B3A-42AE-BAF8-C847A976DDB4

Q37010393-64C9F720-64CD-41E4-8A32-BF1F8031924E

Q37010393-88754D7B-B776-4E6A-B59F-6E330CA502E2

Q37010393-C2A487A2-B840-47ED-A2B7-461B1D48B504

Q37010393-D5ABE233-DB82-4A22-A0F9-D9F531632A12

Q37010393-E6F557A8-0186-4A61-A266-551216735C63

Q37010393-F3BDDFA4-92E5-49CE-B719-1C46508583D7

P2860

Q37010393-06FE5285-EAA6-4775-A133-3962A736B1BD

Q37010393-176A9E0D-8F20-4127-987A-E12B8955098A

Q37010393-19290733-100D-41F5-BD97-C352F2C36A88

Q37010393-21084902-5416-4491-B8B6-6AA3AB792440

Q37010393-247B51FD-6E82-4B40-92E5-8E3084EA60F4

Q37010393-2D4AF867-2AFE-4158-B4DD-5E8C3E9EFD6E

Q37010393-474D7ACC-5495-4F4A-80B0-8D181C038023

Q37010393-584F043D-1BBC-4470-9316-0FF11DA8F6C6

Q37010393-60506266-CB4B-448E-8411-704FAC7DFB95

Q37010393-7A03E24A-E72C-4911-9D73-5187CB9B3D93

P2888

Q37010393-3121BAE7-EA5A-48AD-B3BA-39CCA058CB33

P304

Q37010393-5D058FB5-802F-4E4F-8F65-092051FAD3EA

P31

Q37010393-4443E753-D467-4049-BE5C-57407214F6AB

P356

Q37010393-A1E854A8-855F-4489-A59E-89A36A75B951

P478

Q37010393-8321507A-BE95-4D38-994E-61668107FDAD

P577

Q37010393-22A358AD-1B6A-458D-AFE7-F48E1E6668CC

P5875

Q37010393-F0B47558-E89D-4DA8-A2E3-D3D8C865BC84

P6179

Q37010393-2E4993F0-5E56-4A06-A701-EB9CA337ED4D

P698

Q37010393-519BFCB2-AF11-452D-B8A3-48201FE5EFA0

P921

Q37010393-4C66BCEA-A881-4E3A-A8BE-FDB723829F0D

Q37010393-E418F1F7-F4F0-4A4D-BE15-F3AE20688E10

P932

Q37010393-41079039-4163-48C3-9D3C-373041FE09A9

P356

P1433

Health and Quality of Life Outcomes

P1476

Outcomes of adding second hypo ...... ng type 2 diabetes in Hungary.

@en

P2093

Diana Erdesz

http://www.w3.org/2001/XMLSchema#string

Don Yin

http://www.w3.org/2001/XMLSchema#string

György Jermendy

http://www.w3.org/2001/XMLSchema#string

Hemant Phatak

http://www.w3.org/2001/XMLSchema#string

Hungarian RECAP Group

http://www.w3.org/2001/XMLSchema#string

Laszlo Nagy

http://www.w3.org/2001/XMLSchema#string

Rajesh Balkrishnan

http://www.w3.org/2001/XMLSchema#string

Samuel Engel

http://www.w3.org/2001/XMLSchema#string

Sudeep Karve

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

Diagnosis and classification of diabetes mellitus

Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.

Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.

Hypoglycemia as a barrier to glycemic control.

Combination therapy using metformin or thiazolidinediones and insulin in the treatment of diabetes mellitus.

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes.

A review of the effects of antihyperglycaemic agents on body weight: the potential of incretin targeted therapies.

P2888

P304

88

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1477-7525-6-88

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23443994

http://www.w3.org/2001/XMLSchema#string

P6179

1045586690

http://www.w3.org/2001/XMLSchema#string

P698

18976457

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2600631

http://www.w3.org/2001/XMLSchema#string